HOLX has historically outperformed in July in the last decade
The shares of women's health specialist Hologic, Inc. (NASDAQ:HOLX) are clinging to a 1.6% year-over-year lead. In 2022, however, HOLX sports an 8.6% deficit. While the Hologic stock's current technical setup is less than desirable, July just might serve a silver lining, if past is precedent.
Per a study from Schaeffer's Senior Quantitative Analyst Rocky White, Hologic is one of the best S&P 500 Index (SPX) stocks to own in July. Looking back over the last 10 years, HOLX averaged a July gain of 9.1%,and finished the month higher nine times. From it's current perch at $70.13, a move of similar magnitude would have the equity reclaiming its year-to-date breakeven level.
Now looks like the opportune time to get in on this rally with options. Specifically, HOLX's Schaeffer's Volatility Scorecard (SVS) sits at 88 out of 100, implying the equity tends to outperform volatility expectations.